Viva Biotech: Up to the end of March, a total of 67,025 shares have been repurchased at a cost of nearly 2 million yuan.

Weixin Bio announced that on March 9, 2026, the company approved a share repurchase plan, planning to repurchase with its own funds and specific loans of 80-120 million yuan for employee stock ownership plans or stock incentives. The repurchase period will last until March 8, 2027. On March 11, the company made its first repurchase of 32,000 shares. As of March 31, a total of 67,025 shares have been repurchased, accounting for 0.02% of the total share capital, with the highest price paid being 31.11 yuan per share and the lowest price being 28.60 yuan per share, and a total payment of 1.9972 million yuan.